Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01311440|
Recruitment Status : Completed
First Posted : March 9, 2011
Last Update Posted : September 19, 2017
In Oslo University Hospital, department of complex epilepsy, offer ketogenic diet to treat children with medically intractable epilepsy. From 2009 we added modified Atkins diet as a treatment option for children up to 18 years.
We now initiate an open, prospective, randomized and controlled study with the aim to test the efficacy of treatment with modified Atkins diet in adults with focal and generalized epilepsy diagnoses, in order to evaluate whether this treatment should be offered to patients on a permanent basis.
|Condition or disease||Intervention/treatment||Phase|
|Epilepsy Focal Epilepsy Generalized Epilepsy||Other: Modified Atkins diet treatment||Not Applicable|
Poorly controlled epilepsy in adults affects health and quality of life in many ways. Within this heterogenous population there are individuals who are motivated for a very strict diet in order to reduce seizures.
Among adults with epilepsy 75 - 80 % are diagnosed with focal epilepsy, while 20 - 25 % have generalized onset of seizures.
We plan to include 92 patients with focal epilepsy diagnosis. Those are randomized into diet and control groups.
During the inclusion period we also treat patients with generalized epilepsy that qualify for participation, but these are not to be randomized, rather they will follow the diet group course. We assume 18 - 23 patients with generalized epilepsy will be included in the project.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||75 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy - a Controlled, Randomized Trial|
|Actual Study Start Date :||March 2011|
|Actual Primary Completion Date :||June 2017|
|Actual Study Completion Date :||July 2017|
Experimental: Modified Atkins diet treatment
12 weeks of Modified Atkins diet treatment, recording seizures
Other: Modified Atkins diet treatment
Eat a diet containing 16 grams of carbohydrates per day, maximize on fat. Assure sufficient intake of micronutrients.
No Intervention: No intervention
12 weeks seizure record
- Change in seizure frequency [ Time Frame: 12 weeks ]All participants record detailed seizure records for 12 weeks prior to the control/diet period. The diet group participants are subsequently treated with modified Atkins diet for 12 weeks, while the control group continue their normal diet and record seizures for another 12 weeks. Seizure records for each participant before and during intervention are compared.
- Change in body weight [ Time Frame: 12 weeks ]
- Change in standard 3-hrs EEG [ Time Frame: 12 weeks ]
- Change in life quality measured by validated questionnaire [ Time Frame: 12 weeks ]
- Change in various blood and serum measures [ Time Frame: 12 weeks ]
- Change in executive functions measured with validated questionnaire [ Time Frame: 12 weeks ]
- Change in seizure strength and severity measured by validated questionnaire [ Time Frame: 12 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01311440
|Oslo University Hospital, The national Centre for epilepsy|
|Sandvika, Bærum Postterminal, Norway, 1306|
|Principal Investigator:||Karl Otto Nakken||Oslo University Hospital|